Furthermore, it was reported that transgenic introduction of human sclerostin could inhibit inflammatory cytokines and chemokines, while prevent AA and atherosclerosis progression in ApoE-/- mice with AngII infusion 12. The gene discussed is AGT; the disease is atherosclerosis.